Aiming, Not exactly jumping in, more like dribbling in gradually since I still don't have much available to invest. I'm "aiming for" an eventual 50/50 allocation between fixed income/CDs and equities, which I figure is appropriate for my age (51). I have the CD part in place but not the equity portion, so will use dollar cost averaging as funds become available.
BTW, in addition to Durect, you might want to check out an interesting microcap called Bio-Imaging Technologies (BITI), which even after its recent run still has a market cap under $100 mil. They're the world's largest independent, dedicated provider of medical image management/analysis for clinical trials. The trend is for the FDA to no longer accept image analysis by cooperatives (groups of academic experts), but only by commercial core providers, and Bio-Imaging is the leader. They also have a personal health record software business. Covance has a 20% stake in the company. BTW, Covance is another great company. Unlike CRO competitors who do primarily Phase 2 and 3 clinical trials, two thirds of Covance's revenues are laboratory based - they do the tox/preclinical trials. These CRO "picks and shovels" type companies make money regardless of whether the drugs ultimately succeed or fail, and are much safer than regular bio companies.
News 
Market Data 
Discover 
AI
